A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis

被引:87
作者
Inoue, Yoshiaki [1 ]
Chen, Yu [1 ]
Hirsh, Mark I. [1 ]
Yip, Linda [1 ]
Junger, Wolfgang G. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Surg, Sch Med, Boston, MA 02215 USA
来源
SHOCK | 2008年 / 30卷 / 02期
关键词
A3 adenosine receptor; P2Y2 purinergic receptor; cecal ligation and puncture; sepsis; acute lung injury; neutrophil elastase;
D O I
10.1097/SHK.0b013e318160dad4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We have recently shown that A3 adenosine receptors and P2Y2 purinergic receptors play an important role in neutrophil chemotaxis. Chemotaxis of neutrophils to sites of infections is critical for immune defense. However, excessive accumulation of neutrophils in the lungs can cause acute lung tissue damage. Here we assessed the role of A3 and P2Y2 receptors in neutrophil sequestration to the lungs in a mouse model of sepsis. Sepsis was induced by cecal ligation and puncture (CLP) using adult male C57BL/6J mice (wild type [WT]), homozygous A3 receptor knockout (A3KO) mice, and P2Y2 receptor knockout (P2Y2KO) mice. Animals were killed 2, 4, 6, or 8 h after CLP, and peritoneal lavage fluid and blood were collected. Lungs were removed, and neutrophil infiltration was evaluated using elastase as a marker. Leukocyte and bacterial counts in peritoneal lavage fluid and blood samples were determined. Survival after sepsis was determined in a separate group. Leukocyte counts in the peritoneum were lower in A3KO and P2Y2KO mice than in WT mice. Conversely, initial leukocyte counts in the peripheral blood were higher in KO mice than in WT mice. Neutrophil sequestration to the lungs reached a maximum 2 h after CLP and remained significantly higher in WT mice compared with A3KO and P2Y2KO mice (P < 0.001). Survival after 24 h was significantly lower in WT mice (37.5%) than in A3KO or P2Y2KO mice (82.5%; P < 0.05). These data suggest that A3 and P2Y2 receptors are involved in the influx of neutrophils into the lungs after sepsis. Thus, pharmaceutical approaches that target these receptors might be useful to control acute lung tissue injury in sepsis.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 33 条
[1]   Neutrophils and acute lung injury [J].
Abraham, E .
CRITICAL CARE MEDICINE, 2003, 31 (04) :S195-S199
[2]  
BAKER CC, 1983, SURGERY, V94, P331
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]   Feedback signaling controls leading-edge formation during chemotaxis [J].
Charest, Pascale G. ;
Firtel, Richard A. .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (04) :339-347
[5]   ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors [J].
Chen, Yu ;
Corriden, Ross ;
Inoue, Yoshiaki ;
Yip, Linda ;
Hashiguchi, Naoyuki ;
Zinkernagel, Annelies ;
Nizet, Victor ;
Insel, Paul A. ;
Junger, Wolfgang G. .
SCIENCE, 2006, 314 (5806) :1792-1795
[6]   Multiple organ failure in trauma patients [J].
Durham, RM ;
Moran, JJ ;
Mazuski, JE ;
Shapiro, MJ ;
Baue, AE ;
Flint, LM .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 55 (04) :608-616
[7]   Navigating signaling networks:: chemotaxis in Dictyostelium discoideum [J].
Franca-Koh, Jonathan ;
Kamimura, Yoichiro ;
Devreotes, Peter .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (04) :333-338
[8]   Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning [J].
Guo, Y ;
Bolli, R ;
Bao, W ;
Wu, WJ ;
Black, RG ;
Murphree, SS ;
Salvatore, CA ;
Jacobson, MA ;
Auchampach, JA .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (04) :825-830
[9]   Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock [J].
Haskó, G ;
Xu, DZ ;
Lu, Q ;
Németh, ZH ;
Jabush, J ;
Berezina, TL ;
Zaets, SB ;
Csóka, B ;
Deitch, EA .
CRITICAL CARE MEDICINE, 2006, 34 (04) :1119-1125
[10]   A3 adenosine receptor-mediated protection of the ischemic heart [J].
Headrick, JP ;
Peart, J .
VASCULAR PHARMACOLOGY, 2005, 42 (5-6) :271-279